Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Fifteen-year history of the European head and neck society.

Hoşal Ş, Golusiński W, Andry G, Leemans CR, LeFebvre JL.

Oral Oncol. 2019 Sep 3;97:112-114. doi: 10.1016/j.oraloncology.2019.08.022. [Epub ahead of print] No abstract available.

PMID:
31491674
2.

Reprogramming of Energy Metabolism: Increased Expression and Roles of Pyruvate Carboxylase in Papillary Thyroid Cancer.

Strickaert A, Corbet C, Spinette SA, Craciun L, Dom G, Andry G, Larsimont D, Wattiez R, Dumont JE, Feron O, Maenhaut C.

Thyroid. 2019 Jun;29(6):845-857. doi: 10.1089/thy.2018.0435.

PMID:
30990120
3.

Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study.

Simon C, Caballero C, Gregoire V, Thurnher D, Koivunen P, Ceruse P, Spriano G, Nicolai P, Licitra L, Machiels JP, Hamoir M, Andry G, Mehanna H, Hunter KD, Dietz A, René Leemans C.

Eur J Cancer. 2018 Nov;103:69-77. doi: 10.1016/j.ejca.2018.07.140. Epub 2018 Sep 11. Review.

PMID:
30216847
4.

Quality assurance in head and neck surgery: special considerations to catch up.

Andry G, Hamoir M, Leemans CR.

Eur Arch Otorhinolaryngol. 2018 Aug;275(8):2145-2149. doi: 10.1007/s00405-018-5046-9. Epub 2018 Jun 29.

PMID:
29959567
5.

Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution.

Dom G, Frank S, Floor S, Kehagias P, Libert F, Hoang C, Andry G, Spinette A, Craciun L, de Saint Aubin N, Tresallet C, Tissier F, Savagner F, Majjaj S, Gutierrez-Roelens I, Marbaix E, Dumont JE, Maenhaut C.

Oncotarget. 2017 Dec 8;9(12):10343-10359. doi: 10.18632/oncotarget.23130. eCollection 2018 Feb 13.

6.

Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers.

Tarabichi M, Antoniou A, Le Pennec S, Gacquer D, de Saint Aubain N, Craciun L, Cielen T, Laios I, Larsimont D, Andry G, Dumont JE, Maenhaut C, Detours V.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):1102-1111. doi: 10.1210/jc.2017-02279.

PMID:
29342254
7.

Benign tumors of the parotid gland: a retrospective study of 339 patients.

Quiriny M, Dekeyser C, Moreau M, Digonnet A, Willemse E, Vanbel L, Andry G.

Acta Chir Belg. 2017 Aug;117(4):227-231. doi: 10.1080/00015458.2017.1287394. Epub 2017 Feb 10.

PMID:
28636472
8.

The EORTC module for quality of life in patients with thyroid cancer: phase III.

Singer S, Jordan S, Locati LD, Pinto M, Tomaszewska IM, Araújo C, Hammerlid E, Vidhubala E, Husson O, Kiyota N, Brannan C, Salem D, Gamper EM, Arraras JI, Ioannidis G, Andry G, Inhestern J, Grégoire V, Licitra L; EORTC Quality of Life Group, the EORTC Head and Neck Cancer Group, and the EORTC Endocrine Task Force.

Endocr Relat Cancer. 2017 Apr;24(4):197-207. doi: 10.1530/ERC-16-0530. Epub 2017 Feb 21.

PMID:
28223365
9.

Quality-of-Life Priorities in Patients with Thyroid Cancer: A Multinational European Organisation for Research and Treatment of Cancer Phase I Study.

Singer S, Husson O, Tomaszewska IM, Locati LD, Kiyota N, Scheidemann-Wesp U, Hofmeister D, Winterbotham M, Brannan C, Araújo C, Gamper EM, Kulis D, Rimmele H, Andry G, Licitra L.

Thyroid. 2016 Nov;26(11):1605-1613. Epub 2016 Oct 12.

PMID:
27605136
10.

Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.

Descamps G, Karaca Y, Lechien JR, Kindt N, Decaestecker C, Remmelink M, Larsimont D, Andry G, Hassid S, Rodriguez A, Khalife M, Journe F, Saussez S.

J Cancer Res Clin Oncol. 2016 Oct;142(10):2185-96. doi: 10.1007/s00432-016-2203-7. Epub 2016 Jul 1.

11.

Near infrared fluorescent imaging after intravenous injection of indocyanine green during neck dissection in patients with head and neck cancer: A feasibility study.

Digonnet A, van Kerckhove S, Moreau M, Willemse E, Quiriny M, Ahmed B, de Saint Aubain N, Andry G, Bourgeois P.

Head Neck. 2016 Apr;38 Suppl 1:E1833-7. doi: 10.1002/hed.24331. Epub 2015 Dec 24.

PMID:
26699164
12.

New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.

Saiselet M, Gacquer D, Spinette A, Craciun L, Decaussin-Petrucci M, Andry G, Detours V, Maenhaut C.

BMC Genomics. 2015 Oct 21;16:828. doi: 10.1186/s12864-015-2082-3.

13.

Recurrent invasive thymoma with pleural dissemination : disease management and treatment possibilities.

Konecna J, Willemse E, Lefebvre Y, de Wind R, Andry G.

Acta Chir Belg. 2014 Jul-Aug;114(4):284-8.

PMID:
26021426
14.

Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer.

Tarabichi M, Saiselet M, Trésallet C, Hoang C, Larsimont D, Andry G, Maenhaut C, Detours V.

Br J Cancer. 2015 May 12;112(10):1665-74. doi: 10.1038/bjc.2014.665.

15.

microRNA expression in autonomous thyroid adenomas: Correlation with mRNA regulation.

Floor SL, Trésallet C, Hébrant A, Desbuleux A, Libert F, Hoang C, Capello M, Andry G, van Staveren WC, Maenhaut C.

Mol Cell Endocrinol. 2015 Aug 15;411:1-10. doi: 10.1016/j.mce.2015.04.001. Epub 2015 Apr 23.

PMID:
25916957
16.

Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases.

Le Pennec S, Konopka T, Gacquer D, Fimereli D, Tarabichi M, Tomás G, Savagner F, Decaussin-Petrucci M, Trésallet C, Andry G, Larsimont D, Detours V, Maenhaut C.

Endocr Relat Cancer. 2015 Apr;22(2):205-16. doi: 10.1530/ERC-14-0351. Epub 2015 Feb 17.

PMID:
25691441
17.

MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.

Floor SL, Hebrant A, Pita JM, Saiselet M, Trésallet C, Libert F, Andry G, Dumont JE, van Staveren WC, Maenhaut C.

PLoS One. 2014 Nov 6;9(11):e111581. doi: 10.1371/journal.pone.0111581. eCollection 2014.

18.

miRNA expression in anaplastic thyroid carcinomas.

Hébrant A, Floor S, Saiselet M, Antoniou A, Desbuleux A, Snyers B, La C, de Saint Aubain N, Leteurtre E, Andry G, Maenhaut C.

PLoS One. 2014 Aug 25;9(8):e103871. doi: 10.1371/journal.pone.0103871. eCollection 2014.

19.

Parathyroidectomy in primary hyperparathyroidism: retrospective study of 167 patients, experience in Jules Bordet Institute.

Quiriny M, Moreau M, Alexiou J, Andry G.

Acta Chir Belg. 2014 Mar-Apr;114(2):118-24.

PMID:
25073210
20.

Quality assurance in head and neck surgical oncology: EORTC 24954 trial on larynx preservation.

Leemans CR, Tijink BM, Langendijk JA, Andry G, Hamoir M, Lefebvre JL; Subcommittee of Surgery of the EORTC Head and Neck Cooperative Group.

Eur J Surg Oncol. 2013 Sep;39(9):1013-8. doi: 10.1016/j.ejso.2013.06.007. Epub 2013 Jun 28.

PMID:
23810332
21.

Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence".

Tarabichi M, Antoniou A, Saiselet M, Pita JM, Andry G, Dumont JE, Detours V, Maenhaut C.

Cancer Metastasis Rev. 2013 Dec;32(3-4):403-21. doi: 10.1007/s10555-013-9431-y. Review.

22.

5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro.

Dom G, Galdo VC, Tarabichi M, Tomás G, Hébrant A, Andry G, De Martelar V, Libert F, Leteurtre E, Dumont JE, Maenhaut C, van Staveren WC.

Thyroid. 2013 Mar;23(3):317-28. doi: 10.1089/thy.2012.0388.

23.

mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.

Hébrant A, Dom G, Dewaele M, Andry G, Trésallet C, Leteurtre E, Dumont JE, Maenhaut C.

PLoS One. 2012;7(10):e37807. doi: 10.1371/journal.pone.0037807. Epub 2012 Oct 24.

24.

Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma.

Digonnet A, Hamoir M, Andry G, Vander Poorten V, Haigentz M Jr, Langendijk JA, de Bree R, Hinni ML, Mendenhall WM, Paleri V, Rinaldo A, Werner JA, Takes RP, Ferlito A.

Eur Arch Otorhinolaryngol. 2013 Jul;270(7):1981-9. doi: 10.1007/s00405-012-2220-3. Epub 2012 Oct 26. Review.

PMID:
23100081
25.

Management of salivary gland tumors.

Andry G, Hamoir M, Locati LD, Licitra L, Langendijk JA.

Expert Rev Anticancer Ther. 2012 Sep;12(9):1161-8. doi: 10.1586/era.12.92. Review.

PMID:
23098116
26.

EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.

Lalami Y, Specenier PM, Awada A, Lacombe D, Liberatoscioli C, Fortpied C, El-Hariry I, Bogaerts J, Andry G, Langendijk JA, Vermorken JB.

Radiother Oncol. 2012 Nov;105(2):238-40. doi: 10.1016/j.radonc.2012.08.006. Epub 2012 Sep 16.

PMID:
22989664
27.

Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.

Digonnet A, Hamoir M, Andry G, Haigentz M Jr, Takes RP, Silver CE, Hartl DM, Strojan P, Rinaldo A, de Bree R, Dietz A, Grégoire V, Paleri V, Langendijk JA, Vander Poorten V, Hinni ML, Rodrigo JP, Suárez C, Mendenhall WM, Werner JA, Genden EM, Ferlito A.

Eur Arch Otorhinolaryngol. 2013 May;270(5):1569-80. doi: 10.1007/s00405-012-2172-7. Epub 2012 Sep 13. Review.

PMID:
22972497
28.

[Mastocytosis: revisited with new cytogenetic data].

Vaes M, Vereecken P, de Wind R, Andry G, Li R, Bron D.

Rev Med Brux. 2012 Jan-Feb;33(1):12-21. Review. French.

PMID:
22512145
29.

Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.

Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA; EORTC Head and Neck Cancer Group.

Ann Oncol. 2012 Oct;23(10):2708-14. Epub 2012 Apr 6.

30.

Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes.

van Staveren WC, Beeckman S, Tomás G, Dom G, Hébrant A, Delys L, Vliem MJ, Trésallet C, Andry G, Franc B, Libert F, Dumont JE, Maenhaut C.

Exp Cell Res. 2012 Mar 10;318(5):444-52. doi: 10.1016/j.yexcr.2011.12.022. Epub 2012 Jan 4.

PMID:
22240166
31.

Parathyroid carcinoma: a review with three illustrative cases.

Digonnet A, Carlier A, Willemse E, Quiriny M, Dekeyser C, de Saint Aubain N, Lemort M, Andry G.

J Cancer. 2011;2:532-7. Epub 2011 Oct 27.

32.

Uvular and tonsillar pillar mucosal necrosis as a cause of severe sore throat after orotracheal intubation.

Salengros JC, El Founas W, Velghe-Lenelle CE, Willemse E, Sosnowski M, Andry G, Digonnet A.

Anaesth Intensive Care. 2011 Jul;39(4):772-3. No abstract available.

33.

[Complete destruction of the sino-nasal structures].

Digonnet A, Van der Stappen A, Willemse E, Andry G.

Rev Med Brux. 2010 Nov-Dec;31(6):555-6. French. No abstract available.

PMID:
21290861
34.

Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update.

Hamoir M, Leemans CR, Dolivet G, Schmitz S, Grégoire V, Andry G.

Head Neck. 2010 Jun;32(6):816-9. doi: 10.1002/hed.21386.

PMID:
20474071
35.

Near total thyroidectomy is an optimal treatment for graves' disease.

Digonnet A, Willemse E, Dekeyser C, Vandevelde L, Michel M, Glinoer D, Larsimont D, Andry G.

Eur Arch Otorhinolaryngol. 2010 Jun;267(6):955-60. doi: 10.1007/s00405-009-1174-6. Epub 2009 Dec 25.

PMID:
20035341
36.

Association of duoxes with thyroid peroxidase and its regulation in thyrocytes.

Song Y, Ruf J, Lothaire P, Dequanter D, Andry G, Willemse E, Dumont JE, Van Sande J, De Deken X.

J Clin Endocrinol Metab. 2010 Jan;95(1):375-82. doi: 10.1210/jc.2009-1727. Epub 2009 Dec 1.

PMID:
19952225
37.

[Thyroid cancers].

Andry G, Willemse E, Digonnet A, De Keyser C, Vandevelde L, Plat L, Larsimont D, Muylle K, Lemort M.

Rev Med Brux. 2009 Sep;30(4):279-86. French. Erratum in: Rev Med Brux. 2009 Sep-Oct;30(5):482.

PMID:
19899374
38.

Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager.

Brachet C, Boros E, Tenoutasse S, Lissens W, Andry G, Martin P, Bergmann P, Heinrichs C.

Eur J Endocrinol. 2009 Jul;161(1):207-10. doi: 10.1530/EJE-09-0257. Epub 2009 May 7.

PMID:
19423559
39.

[Quality of life after radical surgery and radiotherapy for advanced or recurrent laryngeal and hypopharyngeal cancers].

Dequanter D, Lothaire P, Eekhout D, Dheur S, Colin M, Andry G.

Rev Laryngol Otol Rhinol (Bord). 2009;130(3):145-9. French.

PMID:
20345069
40.

Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary.

Dequanter D, Lothaire P, Gastelblum P, Nguyen TH, Lalami Y, Awada A, Andry G.

B-ENT. 2008;4(3):157-61.

PMID:
18949962
41.

[Primary lymphoma of the thyroid gland].

Dequanter D, Lothaire P, de Saint-Aubain Somerhausen N, Andry G.

Rev Med Brux. 2008 May-Jun;29(3):177-9. French.

PMID:
18705599
42.

Fistula and stenosis after 135 (pharyngo)laryngectomies.

Dequanter D, Lothaire P, Philippart P, De Wan J, Comblain M, Deraemaecker R, Andry G.

Acta Chir Belg. 2008 Jan-Feb;108(1):98-101.

PMID:
18411582
43.

Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype.

van Staveren WC, Solís DW, Delys L, Duprez L, Andry G, Franc B, Thomas G, Libert F, Dumont JE, Detours V, Maenhaut C.

Cancer Res. 2007 Sep 1;67(17):8113-20.

44.

Long-term EGF/serum-treated human thyrocytes mimic papillary thyroid carcinomas with regard to gene expression.

Hébrant A, van Staveren WC, Delys L, Solís DW, Bogdanova T, Andry G, Roger P, Dumont JE, Libert F, Maenhaut C.

Exp Cell Res. 2007 Sep 10;313(15):3276-84. Epub 2007 Jul 4. Erratum in: Exp Cell Res. 2007 Nov 15;313(19):4082.

PMID:
17689531
45.

Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck cancer: preliminary results.

Dequanter D, Lothaire P, Bourgeois P, Flamen P, Lemort M, Andry G.

Acta Chir Belg. 2006 Sep-Oct;106(5):519-22.

PMID:
17168261
46.

Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?

Dequanter D, Lothaire P, Awada A, Lalami Y, Hien Nguyen T, Lemort M, Vandevelde L, Andry G.

Acta Otolaryngol. 2006 Dec;126(11):1225-8.

PMID:
17050318
47.

Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures.

Chico Galdo V, Massart C, Jin L, Vanvooren V, Caillet-Fauquet P, Andry G, Lothaire P, Dequanter D, Friedman M, Van Sande J.

Mol Cell Endocrinol. 2006 Sep 26;257-258:6-14. Epub 2006 Jul 21.

PMID:
16859826
48.

Wide localized excision and reconstruction for minor salivary gland tumours.

Dequanter D, Andry G, Lothaire P, Larsimont D, Deraemaecker R.

B-ENT. 2005;1(4):187-90.

PMID:
16429751
49.

Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.

van Staveren WC, Solís DW, Delys L, Venet D, Cappello M, Andry G, Dumont JE, Libert F, Detours V, Maenhaut C.

Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):413-8. Epub 2005 Dec 28.

50.

Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.

Lothaire P, de Azambuja E, Dequanter D, Lalami Y, Sotiriou C, Andry G, Castro G Jr, Awada A.

Head Neck. 2006 Mar;28(3):256-69. Review.

PMID:
16284973

Supplemental Content

Support Center